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ABSTRACT
Experimental analysis and manipulation of protein–
DNA interactions pose unique biophysical
challenges arising from the structural and
chemical homogeneity of DNA polymers. We report
the use of yeast surface display for analytical and
selection-based applications for the interaction
between a LAGLIDADG homing endonuclease and
its DNA target. Quantitative flow cytometry using
oligonucleotide substrates facilitated a complete
profiling of specificity, both for DNA-binding and
catalysis, with single base pair resolution. These
analyses revealed a comprehensive segregation of
binding specificity and affinity to one half of the
pseudo-dimeric interaction, while the entire
interface contributed specificity at the level of
catalysis. A single round of targeted mutagenesis
with tandem affinity and catalytic selection steps
provided mechanistic insights to the origins of
binding and catalytic specificity. These methods
represent a dynamic new approach for interrogating
specificity in protein–DNA interactions.
INTRODUCTION
Speciﬁc interactions between proteins and DNA embody
a rigorous molecular recognition challenge (1). DNA
molecules present homogeneous and locally static
structural and electrochemical surfaces which support a
restricted set of mechanisms for the extraction of
binding information. This contrasts with protein–protein
interactions, where the diverse structures and chemistries
of polypeptide surfaces facilitate a high level of binding
speciﬁcity (2). As such, the energetic diﬀerences which
sustain speciﬁcity in protein–DNA interactions are
subtle relative to those in other interacting biomolecules
and diﬃcult to resolve experimentally (3). Additionally,
relationships between binding and catalytic speciﬁcity in
the many classes of DNA-binding proteins which deliver
enzymatic modiﬁcations to speciﬁc targets have remained
elusive.
Technical limitations have prevented routine
quantitative assessments of speciﬁcity in protein–DNA
interactions. While high throughput techniques to
analyze protein–DNA binding have been described
(4–10), these methods have not achieved widespread use
because of their inherent complexity, costly reagent or
apparatus set-up, and a failure to provide selection-
based applications which support dynamic testing of
protein variants. Moreover, no current technique provides
the capacity to assess relationships between binding
interactions and subsequent catalytic events. An analytical
platform that enables quantitative interrogation of
binding and catalytic speciﬁcity and which also facilitates
the rapid analysis of protein variants would represent a
signiﬁcant advance for studies of DNA-interacting
proteins. Translating such a platform to high throughput
library screening would supplement a ﬂexible analytical
method with selection capabilities useful for mechanistic
studies of protein–DNA interactions as well as protein
engineering applications.
Yeast surface display (YSD) is a widely used platform
for the manipulation of intermolecular binding interac-
tions and has been successfully applied to engineer
desired properties into multiple types of proteins (11,12).
Its utility has been further extended by the development of
rapid ﬂow cytometric methods that allow quantiﬁcation of
binding aﬃnity with results paralleling that of standard
biophysical methods, but without a requirement for
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transformation protocols and yeast’s intrinsic capacity
for homologous recombination of transfected DNA
allow facile production of large and complex molecular
libraries (14). The relatively robust, neutral and
non-reactive nature of the yeast cell wall is ideal for
ﬂow cytometry applications, and is compatible with a
wide variety of conditions necessary for eﬃcient catalysis
by surface displayed enzymes. Additionally, the
eukaryotic translational machinery and its associated
chaperones and quality control mechanisms provide a
stringent folding checkpoint, ensuring that molecular
variants emerging from YSD-based selection are stable
and well folded (15,16). This is particularly important
in eﬀorts to engineer molecules whose downstream
applications require eﬃcient expression in mammalian
cells.
The LAGLIDADG family is a group of proteins with
DNA recognition properties adapted for speciﬁc target
recognition and, in many cases, DNA cleavage (17,18).
DNA targets recognized by LAGLIDADG proteins
range in length from 16–22 base pairs, making them
some of the most speciﬁc DNA recognition molecules
known in nature and a unique model for the study of
protein–DNA interactions. Additionally, LAGLIDADG
proteins have emerged as an important class of molecules
for delivering endonuclease activity—or potentially other
modalities—to select loci in biotechnology and therapeutic
applications (19–22). Widespread use of LAGLIDADG
proteins in genome targeting applications hinges on
achieving a comprehensive understanding of the
mechanistic contributions to speciﬁcity. While interactions
between some members and their native DNA targets
have been well characterized structurally and thermo-
dynamically (23), biochemical analyses and engineering
strategies have depended heavily on readouts of
endonuclease activity (22,24–32). As such, the longitudinal
contributions of intermolecular interactions that govern
speciﬁcity remain unappreciated, as no study has system-
atically correlated binding speciﬁcity with endonuclease
activity. Conversely, current experimental strategies to
correlate structural, binding, and catalytic properties are
limited in their adaptability to high throughput analytical
or selection platforms (10,33,34).
Here we report the adaptation of the YSD platform to
enable the study of protein–DNA interactions both at the
level of substrate binding and catalysis. Flow cytometric
methods to quantify interactions with DNA substrates
bearing single mutations were developed and used to
proﬁle the binding and cleavage properties of a
prototypical homing endonuclease. We demonstrate how
such analyses can be applied to uncover local determi-
nants of speciﬁcity as well as regional contributions to
substrate aﬃnity. Our results were then used to inform
a selection strategy that incorporated aﬃnity and
cleavage steps in tandem. In a single round of selection,
this process generated variants whose biophysical
properties were rapidly assessed on the yeast surface, the
results of which provided new insights into the
mechanistic correlations of binding and catalytic
speciﬁcity for LAGLIDADG protein function.
MATERIALS AND METHODS
DNA constructs and substrates for binding and
cleavage assays
The restriction site embedded ORF (REOAni) was
designed using the EMBOSS ‘Silent’ web application
(http://emboss.sourceforge.net/) and codon optimized
for yeast expression (Blue Heron Biotechnology).
Biotinylated and/or ﬂuorophore-conjugated double-
stranded oligonucleotides (ds-oligos) and their comple-
ments were mixed at equimolar concentrations and
annealed or generated using PCR and puriﬁed from
single-stranded contaminants by Exo1 digestion (New
England Biolabs) and size exclusion through a G-50 or
G-100 column (GE Healthcare), then analyzed for purity
by gel electrophoresis (determined to be >98%). See
Supplementary Data online for oligonucleotide sequences
used in all applications.
Yeast growth, transformation, library construction and
plasmid recovery
Saccharomyces cerevisiae strain EBY100 was transformed
using the lithium-acetate (LiAc) method (35). For library
construction, error-prone PCR was performed over the
STS3/4 region of the I-AniI ORF using the GeneMorph-
II Random Mutagenesis kit (Stratagene) according to the
manufacturer’s protocol. Library size for the STS3/4
library was determined by serial dilution to be 0.5 10
6
unique transformants. Mutation distribution and
frequencies were veriﬁed by sequencing an unselected
library and determined to be in the range of 0.5–1.0
mutations per kilobase with no major biasing of the type
or positions of mutations. Yeast propagation was perf-
ormed in the presence of 2% raﬃnose +0.1% glucose at
30 C for at least 12h prior to induction. Cells were
induced in 2% galactose for 2–3h at 30 C followed by
18–26h at 20 C. Plasmids were isolated from yeast popu-
lations using the Zymoprep-II kit (Zymo Research) and
electroporated into Escherichia coli DH10B (Invitrogen)
for ampliﬁcation and/or sequencing. Sequencing was
performed on 40–60 clones for a given selection output.
Flow cytometry
Flow cytometric binding analyses were performed using a
buﬀer containing 10mM HEPES, 10mM NaCl, 180mM
KCl, 5mM CaCl2, 0.1% galactose, 0.2% BSA, pH 7.5.
For Kd determination, roughly 2–5 10
5cells/well were
stained in a ﬁnal volume of 100ml, corresponding to an
approximate concentration of 100pM (assuming 10
4–10
5
molecules per yeast surface). Serial dilutions of substrate
ranging from  5mM to 0.1nM were used for staining.
Samples were incubated at 4 C for 2–4h to achieve
equilibrium then washed twice in excess staining buﬀer
and counterstained with streptavidin-phycoerythrin (PE)
(BD biosciences), ﬂuorescein isothiocyanate (FITC)-
conjugated anti-Myc (ICL Labs), and an amine-reactive
viability dye, Alexa ﬂuor 350 succinimidyl ester
(Molecular Probes). All analytical ﬂow cytometry
samples were acquired on a BD LSRII
TM cytometer
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Binding aﬃnity calculation
Epitope-normalized values for substrate binding were
determined for each sample. This value was established
as the median PE ﬂuorescence in a 10% cell gate of
FITC ﬂuorescence. This gate position, which generated
normally distributed PE ﬂuorescence data from  2000
cells per sample, was held constant across the entire
experimental analysis. Median PE values were plotted
versus ds-oligo concentration and the resulting
distribution was ﬁt using iterative least-squares modeling
to the equation for equilibrium binding:
Y ¼
Bmax  ½ L 
Kd þ½ L 
þ A:
In the VisualEnzymics (SoftZymics) module for IGOR
Pro 6 (WaveMetrics), where [L] is the concentration of
substrate and Y is the measured median PE value for a
given Myc-normalized sample. Non-linear regression
analysis was applied using the Levenberg-Marquart
(LM) Robust algorithm to isolate the maximum bound
ligand, Bmax and the dissociation constant, Kd. Samples
were weighted towards the lower ds-oligo concentrations
which showed the least variation across samples. The
constant term, A, was included to adjust for the median
ﬂuorescence value of unstained cells for a given
cytometer’s photomultiplier tube voltage setting.
Substrate binding competition assay
His-tagged recombinant I-AniI was immobilized in nickel-
NTA coated HisSorb plates by incubation of a 100nM
solution in TBS (50mM Tris–HCl pH 7.5, 150mM
NaCl) with 0.2%BSA for 2h at room temperature,
followed by four washes with TBS containing 0.05%
Tween-20. Each well was incubated for 2h with a
mixture of 100nM labeled wild-type target and 3mM
unlabeled competition substrate in 200ml TBS with
0.02mg/ml poly(dI–dC) and 10mM CaCl2. The plates
were washed four times with TBS and the ﬂuorescent
signal retained in each well was quantiﬁed using a
SpectraMax M5/M5e micro-plate reader (Molecular
Devices). Additional negative control experiments
performed in the absence of the enzyme indicated that
no signiﬁcant detectable background ﬂuorescence.
Relative binding aﬃnities were calculated using the
following equation: {[(F(n)–F(x)] F(t)}/{[(F(n) 
F(t)] F(x)}, where F(x), F(t) and F(n) indicate ﬂuorescent
intensities obtained from wells in which the immobilized
protein was incubated with the unlabeled single base-pair
substitutions, target sites and negative control sequence,
respectively (36).
In vitro cleavage assay
Assuming a maximum of 10
5 molecules per yeast cell
surface (11), the ﬁnal concentration of enzyme was
estimated at 3nM in a 50ml reaction containing 1 10
6
displaying yeast. Samples were incubated with 50nM
Alexa-647-conjugated ds-oligo in a buﬀer containing
150mM KCl, 10mM NaCl, 10mM HEPES, 5mM
MgCl2 (or CaCl2 where indicated), 5mM DTT, 0.5mg/
ml BSA, pH 8.25 and placed at 37 C (or indicated
temperatures for thermal titration) for 1h. Supernatants
were extracted once with phenol and run on a 12–15%
non-denaturing polyacrylamide gel. Quantiﬁcation was
performed with an Odyssey infrared imaging system
(Li-Cor Biosciences).
On-cell ds-oligo cleavage
Approximately 2 10
5 induced cells were stained ﬁrst with
1:300 dilution biotinylated anti-HA (Covance), then with
pre-conjugated streptavidin-PE:biotin-DNA-A647 in the
same buﬀer used for binding assays, absent of divalent
cations. Samples were washed twice in the buﬀer described
for the in vitro cleavage assay (lacking DTT) and then
transferred to cleavage buﬀer containing 10mM of
either CaCl2 or MgCl2, and placed at 37 C for the
indicated time points. For kinetic analyses, cells were
prepared as in the ﬁrst two staining steps and transferred
to ice-cold cleavage buﬀer lacking divalent ions.
Immediately prior to acquisition, cells were spiked with
an excess of cold buﬀer containing divalent ions and
placed in the acquisition chamber pre-warmed to 37 C.
Cells were acquired continuously for 8–10min.
Cell sorting
For cell sorting on the basis of substrate binding,
10–50 10
6cells per sample were stained with 30–50nM
ds-oligo in a ﬁnal volume of 1ml, then washed twice and
counterstained with SA-PE, anti-Myc-FITC and Alexa
ﬂuor 350 succinimidyl ester and hierarchically gated as
described above but processed on a BD FACSAria
TM II
cell sorter. Maximal phase and purity masking were
employed. Ten-fold sampling of the estimated library
size was processed to ensure coverage of the total
variability and  5000–50000 cells were sorted at each
round. For cleavage based sorting, samples were
prepared as described for the on-cell assay yet scaled up
10–50-fold depending on the size of the input population.
RESULTS
Flow cytometric interrogation of DNA-binding speciﬁcity
A potential hurdle in applying YSD to intracellular
proteins is the risk that their expression on the cell
surface may compromise native functions. Exposure to
non-native cellular compartments could abolish folding
or incur post-translational modiﬁcations that aﬀect func-
tion. To address whether a monomeric LAGLIDADG
protein could be expressed on the yeast cell surface, we
fused a full-length I-AniI homing endonuclease to the
secreted protein Aga2p (11) (Figure 1a) and developed
assays to conﬁrm that native binding and catalytic
functions were maintained.
Substrate interactions were quantiﬁed using equilibrium
ligand binding approximations analogous to those used
in the exploration of protein–protein interactions in
Nucleic Acids Research, 2009,Vol.37, No. 20 6873this surface display system (13). Biotinylated ds-oligo
substrates were used as staining reagents in ﬂow cytometry
assays on yeast cells displaying I-AniI. For a given
concentration of DNA substrate, samples were incubated
to equilibrium and the amount of bound substrate was
detected by a secondary staining step with streptavidin-
PE (Figure 1b). An antibody to the C-terminal Myc
epitope was added coincident with this secondary
detection step to evaluate substrate-binding capacity as a
function of surface expression. Staining with ds-oligos
encompassing I-AniI’s wild-type target site generated a
signal that ﬁt a standard one-site binding equation with
an approximate dissociation constant (Kd) of 30nM. This
value for I-AniI is consistent with those obtained by
traditional biophysical methods for Kd determination
(23), as has been generally observed during the charac-
terization of protein–protein interaction aﬃnities on the
yeast surface (13). Signiﬁcant signal reductions were
observed when yeast expressing I-AniI were stained with
targets bearing a single base pair substitution predicted
from structural data to disrupt direct hydrogen bond
contacts (37).
Equilibrium binding interactions were next evaluated
for a panel of ds-oligo substrate analogs representing
the three alternative bases at all target site positions
(Figure 1c). Our analysis revealed that I-AniI’s
N-terminal domain discriminates with exclusive speciﬁcity
at multiple positions of the corresponding ( ) half-site.
A comparison of the binding speciﬁcity proﬁle of
I-AniI’s N-terminal domain with contacts identiﬁed in
the crystal structure indicates that hydrogen bond interac-
tions are highly exclusive determinants of target site
speciﬁcity in this region of the interface. In contrast with
the strict direct binding readout observed for the
N-terminal domain, there is a striking lack of binding
speciﬁcity within the C-terminal domain that can be
attributed to any one position along the (+) half-site.
Cross-validation of the ﬂow cytometric assay for
equilibrium binding proﬁling using a substrate competi-
tion assay conﬁrmed that the surface displayed enzyme
exhibits similar speciﬁcity characteristics as recombinant
I-AniI (Supplementary Figure S1). These results imply
that the majority of high-resolution binding discrim-
ination is accomplished by I-AniI’s N-terminal domain,
and highlight the value of a direct quantitative assay for
describing local binding speciﬁcity contributions in
protein–DNA interactions.
Proﬁling catalytic speciﬁcity
Monitoring DNA hydrolysis on the cell surface via ﬂow
cytometry would enable both high-throughput analyses of
catalytic speciﬁcity as well as clonal isolation of active
enzymes from libraries of variants. To this end, an
on-cell ﬂuorophore release assay was devised for ﬂow
cytometric interrogation of cleavage events (Figure 2a).
Substrates containing 50-biotin and (on the complemen-
tary strand) 50-Alexa ﬂuor-647 were generated by PCR
and conjugated to streptavidin-PE at ratio that preserves
biotin-binding sites. These complexes were then tethered
to the yeast surface through biotinylated antibodies
to the HA or Myc epitope tags of the Aga2p-I-AniI
fusion. Tethering in this manner immobilizes biﬂuorescent
DNA substrates proximal to I-AniI, poised for cleavage,
yet does so independently of interactions with the
Figure 1. Proﬁling protein–DNA binding speciﬁcity. (a) Schematic representation of the Aga2p-REOAni expression construct. Silent restriction sites
unique within the vector and embedded adjacent to domain boundaries are indicated. A corresponding structural diagram (PDB ﬁle: 2QOJ) with
emphasis on the motifs that comprise the N-terminal (STS1, STS2) and C-terminal (STS3, STS4) DNA-binding domains and annotated target
sequence are shown below. NTD, N-terminal domain; CTD, C-terminal domain; LAG, LAGLIDADG helix; STS, strand-turn-strand; G4S,
3 (Gly)4-Ser linker motif. (b) Flow cytometry contour plots for equilibrium titration staining with increasing concentrations of four ds-oligo
substrates. For the wild-type target, Myc epitope normalization gates are shown with the ds-oligo:SA-PE median ﬂuorescence intensity levels
marked. Non-linear regression curves (see ‘Materials and Methods’ section) for binding aﬃnity measurements using epitope-normalized ﬂuorescence
values from ﬂow cytometry stains are shown in the adjacent panel. (c) Equilibrium binding curves from a representative experiment with target site
substrate analogs bearing each single mutation across I-AniI’s native target sequence. The curve representing I-AniI’s interaction with its native
target is reproduced on each plot for comparison.
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a productive complex is placed in conditions which
support catalysis, the speciﬁc release of the non-tethered
ﬂuorophore, A647, generates a measurable deviation in
the linear ratio of the two signals (Figure 2b), while a
catalytically inactive interaction or any spurious non-
cleaved substrate release events maintain a scaled linearity
between the two ﬂuorophores. Limiting titrations of yeast
expressing active I-AniI into a population expressing an
inactive variant were performed to conﬁrm that cleavage
of the tethered substrate was catalyzed by endonucleases
displayed on the same cell—a necessary pre-condition for
clonal isolation (Supplementary Figure S3).
As in the substrate-binding experiments, speciﬁcity
proﬁling at the level of target cleavage was performed
using a panel of singly-mutated substrate analogs.
Cleavage activity closely paralleled binding speciﬁcity in
the N-terminal domain; positions with high binding
speciﬁcity (positions  9,  7,  6,  4) also displayed
stringent catalytic speciﬁcity, while those with diminished
binding speciﬁcity (positions  10,  8,  5) also showed
the most promiscuous readout of catalysis (Figure 2c).
Position +3 was unique in that binding discrimination
was not as complete as at positions more distal to the
active site, yet catalytic speciﬁcity does not appear to be
compromised. These results were conﬁrmed using a
traditional in vitro assay for endonuclease activity,
verifying the on-cell assay as a high-throughput technique
for investigating endonuclease speciﬁcity (Figure 2d).
Binding and cleavage correlations broke down signiﬁ-
cantly in the C-terminal domain. Substrates with
mutations in the (+) half-site which bind to I-AniI with
imperceptible diﬀerences in aﬃnity showed dramatic
discrepancies in cleavability. Base changes at positions
+3, +4, +6 and +7 all appear to be eﬃciently discrimi-
nated at the level of catalysis without imparting resolvable
Figure 2. Proﬁling endonuclease catalytic speciﬁcity. (a) Schematic representation of the on-cell cleavage assay before (left), during (middle) and after
(right) transition to conditions which support substrate cleavage. PE, phycoerythrin; A647, Alexa ﬂuor 647. For clarity, tethering and cleavage in the
schematic is shown to occur in cis, however, it is most likely that cleavage events occur in trans, as only minimal orientation eﬀects have been
observed when using HA versus Myc epitopes to tether substrate. (b) Flow cytometry dot plots and corresponding histograms monitoring the
ﬂuorescence proﬁle of wild-type, WT, versus a non-cleaving, NC, mutant in the on-cell cleavage assay in the presence of divalent cations which either
inhibit (Ca
2+) or support (Mg
2+) catalysis. (c) Flow cytometry histograms from a representative proﬁling experiment where each PCR-generated
substrate was conjugated to SA-PE and tested for cleavage by overlaying the A647 signal following incubation in cleavage buﬀer with Ca
2+ or Mg
2+
ions. The shaded wild-type proﬁle is reproduced at each position for comparison with the unshaded one-oﬀ substrates. (d) In vitro cleavage assay
performed on PCR-generated targets conﬁrming that the ﬂuorescence shift in A647 during on-cell speciﬁcity proﬁling correlates with the formation
of cleaved product in a classical endonuclease reaction in solution. W, ds-oligo with I-AniI’s wild-type target sequence; R, substrate with a random
DNA sequence.
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speciﬁcity by the C-terminal domain is not easily
accounted for by a simple direct readout mechanism,
suggesting a global asymmetry in the nature of I-AniI’s
interaction with its substrate.
Probing regional binding aﬃnities
The lack of binding speciﬁcity in the C-terminal domain’s
interaction with the (+) half-site may result from
qualitative and/or quantitative mechanistic contributions.
This distinction is especially relevant when considering
speciﬁcity redesign in this region of the interaction. Since
ﬂow cytometric measurements of A647 release as
described earlier encompass two sequential events in the
endonuclease-target interaction—catalysis and product
release—we applied real-time monitoring of ﬂuorophore
loss to test whether global quantitative diﬀerences in
binding aﬃnity to the cleaved half-site products exist on
either side of the complex. Biﬂuorescent substrates with
A647 conjugated to either end of the target sequence were
tethered to surface displayed I-AniI (Figure 3a). The rate
Figure 3. Half-site product release and truncated substrate binding to isolate N- and C-terminal domain contributions to aﬃnity. (a) Tethering scheme
for evaluating product release events in real time by placing the biotin moiety and A647 ﬂuorophore on either side of the DNA substrate. The black line
connecting the substrate and the epitope tag (either HA or Myc, independent of which end of the substrate is tethered to Alexa 647) represents the
tethering apparatus as described in Figure 2a. (b) Kinetic traces of ( ) versus (+) half-site cleavage/release rates, deﬁned by the position of the Alexa
647 ﬂuorophore, when tethered either to HA or Myc epitopes demonstrating a much faster ﬂuorophore loss signal when conjugated to the (+) half-site.
(c) Despite a faster ﬂuorophore release signal when monitoring cleavage and release of (+) half-site, the relative rates of substrate cleavage were
comparable in either substrate orientation and only minor diﬀerences were observed using diﬀerent epitopes for tethering. (d) Equilibrium binding
curves for a representative half-site substrate binding experiment in which truncated substrates were used—in combination with unlabelled blocking
substrates representing the opposite half-site—to isolate the relative binding aﬃnities of the two halves of the pseudo-dimeric complex; a 5-fold higher
aﬃnity of the N-terminal domain: ( ) half-site interaction [Kd of  800nM versus 4000nM for the C-terminal domain: (+) half-site interaction] was
observed, while a single mutation at position  6 in the ( ) half-site drops its aﬃnity below that of the C-terminal domain.
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when A647 was conjugated to the (+) half-site, indicating
that this side of the complex is released more rapidly than
the ( ) half-site following catalysis (Figure 3b). This
observation indicates that the C-terminal domain (+)
half-site interaction is of lower basal aﬃnity relative to
the other side of the complex, as cleavage activity was
determined to be independent of either the substrate
orientation or tethering epitope (Figure 3c).
To conﬁrm these ﬁndings, we isolated regional contribu-
tions to substrate binding by performing equilibrium
binding analysis with truncated substrates consisting of
only the ( ) and (+) half-sites. A substantially higher
aﬃnity between I-AniI’s N-terminal domain and the ( )
half-site was observed, as the Kd value for this side of
the interaction was 5-fold lower than that between the
C-terminal domain and the (+) half-site (Figure 3d).
This large discrepancy in binding aﬃnity, where >80%
of the binding energy is contained within the interaction
between the N-terminal domain and the ( ) half-site,
suggests that the low aﬃnity of the interaction between
I-AniI’s C-terminal domain and the (+) half-site results
in an apparent lack of binding speciﬁcity in this region of
the complex.
Selection for high-aﬃnity endonucleases
The results above demonstrate that I-AniI’s C-terminal
domain supplies catalytic speciﬁcity in spite of minimal
binding aﬃnity and speciﬁcity towards its native target.
We therefore sought to identify high-aﬃnity C-terminal
domain variants with the expectation that the identity
and position of recovered mutations in this region, and
their eﬀects on catalytic performance, might enable a
more detailed understanding of the observations described
above. To achieve this, we carried out a targeted mutage-
nesis and tandem aﬃnity/activity selection procedure,
applying the analytical tools described earlier in
conjunction with ﬂow sorting. Silent restriction sites
embedded at motif and domain boundaries (Figure 1a)
enabled targeted variation of a region comprising a 250
base pair stretch from the LAGLIDADG motif to STS4
of the C-terminal domain (38).
A library of I-AniI variants was ﬁrst sorted by ﬂow
cytometry for the top performing binders to the wild-
type target site, generating a population of cells which
stained brighter with DNA substrates following a single
round of mutation/selection (Figure 4a). Following
sequencing, clones were derived bearing individual
Figure 4. Selection of high-aﬃnity I-AniI variants reveals a positional correlation of binding aﬃnity versus catalytic contributions to speciﬁcity.
(a) Flow cytometry plots representing the pre- and post-sort populations of a strand-turn-strand 3 (STS3)/STS4 mutagenized library relative to the
wild-type enzyme when selected for binding to the native target sequence. (b) Structural representation of positions where mutations (side chains
shown in green, highlighted with black circles if contacting the phosphoribosyl backbone, red circles if contacting the DNA bases) were enriched
following selection. Active site Mg
2+ ions depicted as magenta spheres, and the phosphoribosyl backbones of each strand are shown in cyan and
orange. (c) Flow cytometry plot and histograms of control (Ca
2+) and experimental (Mg
2+) conditions during sorting for catalytic activity
performed on the output population selected for high binding aﬃnity. (d) In vitro endonuclease assay conﬁrming that variants enriched or
depleted during activity-based selections were catalytically active and inactive, respectively.
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to conﬁrm their impact on binding aﬃnity, with all clones
analyzed demonstrating increases in binding aﬃnity to
the native target sequence (Supplementary Figure S4). In
relating the positions of the mutated residues to the crystal
structure of the complex, we found that they were skewed
towards positions contacting or immediately proximal to
the phosphoribosyl backbone of the DNA strand which
culminates in the active site of the C-terminal domain
(Figure 4b). Mutations at R172 and Q171 would likely
produce side chains contacting the DNA backbone at
the +1 and +2 positions, respectively, immediately 50 of
the hydrolyzed phosphodiester bond. E148 is a critical
active site residue which coordinates a Mg
2+ ion at the
scissile phosphate belonging to position +3. Indeed, the
eﬀect of conservatively mutating residue E148 to an
aspartate residue (E148D), thereby retracting a Mg
2+
ion-coordinating carboxyl group by the length of a
single C–C bond, is a 5-fold improvement in binding
aﬃnity. C150, S152 and K155 are situated along the
DNA backbone 30 of the active site at positions +4 +5
and +6. This pattern suggests that the orientation of the
native enzyme–substrate complex results in binding
penalties along the phosphoribosyl backbone that limit
aﬃnity in the C-terminal domain.
Flow sorting for catalysis was next used to isolate
variants from the high-aﬃnity pool that maintained
endonuclease activity, generating a population of cells
which released A647 in a Mg
2+-dependent manner
(Figure 4c). Cells isolated from this process were enriched
with the non-mutated wild-type I-AniI ORF and the
variant bearing the L156R mutation, yet did not contain
anyofthehigh-aﬃnityvariantswithmutations atpositions
contacting the C-terminal phosphoribosyl backbone. An
in vitro cleavage assay conﬁrmed the eﬀect of the recovered
mutations on catalysis relative to wild-type I-AniI (Figure
4d). The discovery that all the mutations which enhance
aﬃnity through modulating contacts with the phospho-
ribosyl backbone are uniformly inactive, while the one
recovered high-aﬃnity active variant is positioned distal
to the active site and contacts the DNA bases, supports
the concept that speciﬁcity in the C-terminal domain is
coupled to catalysis and independent of binding discrimi-
nation.TheobservationthattheL156Rmutationenhances
both aﬃnity and catalytic activity yet does not alter
regional target binding or cleavage speciﬁcity (Supple-
mentary Figure S5) suggests that, in contrast with the
N-terminal domain, the C-terminal domain uses a
mechanism for target discrimination that does not
correlate with contributions to binding aﬃnity.
DISCUSSION
The YSD-based analytical tools described herein oﬀer a
ﬂexible quantitative method for describing DNA-binding
and cleavage speciﬁcity without the need for protein
puriﬁcation or complex substrate arrays. Contributions
to speciﬁcity from individual protein–DNA contacts are
easily discriminated at single nucleotide resolution by ﬂow
cytometric interrogation. While previous attempts using
mammalian cell surface display were able to resolve
single base pair diﬀerences in binding aﬃnity (10), con-
version of such a system to selection on a catalytic
parameter was unsuccessful due to the toxicity of the
conditions necessary for eﬃcient endonuclease activity.
The techniques described here represent the ﬁrst
application, to our knowledge, where high-resolution
analysis of protein–DNA binding and cleavage speciﬁcity
can be seamlessly translated to a high throughput selection
platform.
Our study demonstrates the application of YSD
techniques in the study and manipulation of the binding
and cleavage properties of a prototypical LAGLIDADG
homing endonuclease, I-AniI. By proﬁling the speciﬁcity
contributions of each position in the native DNA
substrate of I-AniI, we uncovered a surprising functional
asymmetry between I-AniI’s two structurally symmetric
domains. Local binding speciﬁcity and regional binding
aﬃnity was found to be concentrated to the interface
between the N-terminal domain and the ( ) half-site of
the substrate, yet analysis of cleavage speciﬁcity indicated
that mechanisms which supply catalytic discrimination are
present throughout the complex, including areas where no
obvious alterations in binding aﬃnity are present.
The observed discordance in binding and catalytic
speciﬁcity at the C-terminal domain could be accounted
for by aﬃnity-based discrimination that is below the
resolution limit of the YSD assay or the existence of an
aﬃnity-independent mechanism that directly inﬂuences
the enzyme active site. To diﬀerentiate between these
possibilities, we randomly mutagenized the C-terminal
domain of I-AniI, and sorted the resulting library for
variants with increased aﬃnity, but without regard
for catalysis. If a solely aﬃnity-based discrimination
mechanism were operative, an even distribution of
aﬃnity increasing mutations over the protein/DNA
interface surface would be expected in the output, as
beneﬁcial aﬃnity improving mutations could occur at
any protein/DNA contact. Remarkably, all but one of
the aﬃnity-increasing mutations were localized to the
DNA backbone proximal to the active site, and all of
these were incompatible with catalysis. This result
suggests that the interaction between the C-terminal
domain’s active site and the nearby phosphoribosyl
backbone is a critical conformational checkpoint in
catalytic discrimination.
The conformation checkpoint described above appears
to limit the overall aﬃnity of the interaction between
I-AniI and its native DNA target. Consistent with this,
the single distal mutation, L156R, which enhanced the
aﬃnity of the C-terminal domain did not degrade or
alter catalytic speciﬁcity. Thus, in contrast with the
aﬃnity-dependent mechanism of catalytic speciﬁcity that
our data implies in the N-terminal domain: ( ) half site
interaction, these data suggest that a stringent
conformational checkpoint endows catalytic speciﬁcity
to the C-terminal domain. A related study recently
identiﬁed a hyperactive I-AniI variant, called ‘Y2’, which
contains two mutations, F13Y and S111Y, in the
N-terminal domain which enhance the overall aﬃnity of
the complex (39). The crystal structure of this variant
6878 Nucleic Acids Research, 2009,Vol.37, No. 20demonstrated an alteration in the geometry of the
N-terminal domain’s active site. We tested the speciﬁcity
of the Y2 variant displayed on the yeast surface
(Supplementary Figure S6). Our data demonstrates that
the enhanced aﬃnity of the N-terminal domain results in
a modest reduction in the speciﬁcity within the complex,
yet that the general speciﬁcity patterns follow that of
the wild-type enzyme. More detailed kinetic analyses
of these variants should provide a more thorough under-
standing of the asymmetric nature of speciﬁcity in the
complex between I-AniI and its substrate.
In light of the growing ﬁeld of LAGLIDADG
engineering and re-speciﬁcation, further investigation
into the mechanistic origins of speciﬁcity and their
impact on in vivo activity is warranted. Evaluating
regional and local eﬀects of increased aﬃnity may
enable the development of more appropriate position
speciﬁc scoring matrices (PSSMs) to identify optimal
genomic HE targets, and thereby assist in eﬀorts to
redirect HE speciﬁcity. Computational all-atom modeling
and redesign eﬀorts will be aided tremendously by
proﬁling the local and global binding eﬀects of direct
protein–DNA contacts (40). YSD also provides a highly
ﬂexible platform for testing large numbers of variants
generated through computational or directed evolution
approaches to redirect target speciﬁcity.
Detailed quantitative descriptions of DNA-binding
speciﬁcity will have a direct impact on design, engineering,
and directed evolution of protein–DNA interactions.
Experimental systems which facilitate comprehensive
characterization of the speciﬁcity of such interactions
will become increasingly relevant as therapeutic and
biotechnological approaches utilizing DNA-binding and/
or cleaving molecules become more widespread. The
methods described here facilitated a rapid and detailed
analysis of the substrate binding and cleavage relation-
ships in a representative enzyme–substrate interface that
is the focus of a concerted engineering eﬀort aimed at
redeﬁning target speciﬁcity. Their application has
demonstrated both parsimony and discordance in the
interrelationships between DNA binding and catalysis
within a single enzyme.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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